Birch Hill Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,200
Closed -$149K 131
2017
Q1
$149K Buy
+2,200
New +$155K 0.01% 130
2016
Q4
Sell
-3,156
Closed -$250K 128
2016
Q3
$250K Sell
3,156
-180
-5% -$14.6K 0.02% 119
2016
Q2
$278K Buy
3,336
+30
+0.9% +$2.66K 0.03% 116
2016
Q1
$304K Sell
3,306
-320
-9% -$28.9K 0.03% 112
2015
Q4
$367K Buy
3,626
+320
+10% +$33.3K 0.04% 108
2015
Q3
$325K Sell
3,306
-100
-3% -$11.1K 0.04% 112
2015
Q2
$399K Hold
3,406
0.04% 109
2015
Q1
$334K Sell
3,406
-100
-3% -$10.2K 0.03% 116
2014
Q4
$330K Hold
3,506
0.03% 117
2014
Q3
$373K Buy
+3,506
New +$343K 0.04% 109
2014
Q1
Sell
-2,800
Closed -$210K 138
2013
Q4
$210K Sell
2,800
-600
-18% -$41.8K 0.02% 134
2013
Q3
$214K Buy
+3,400
New +$203K 0.03% 132

Other funds holding GILD

Birch Hill Investment Advisors's GILD Position: Q2 2017 in Review

Birch Hill Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 2,200 shares — an estimated $149K sold.

Birch Hill Investment Advisors first reported a position in GILD in Q3 2013 and held it in 12 quarters. The position peaked at $399K in Q2 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Birch Hill Investment Advisors reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Birch Hill Investment Advisors sold 2,200 Gilead Sciences shares in Q2 2017, an estimated $149K.
  • Birch Hill Investment Advisors first reported a position in Gilead Sciences in Q3 2013 and held it in 12 quarters.
  • Birch Hill Investment Advisors's Gilead Sciences position peaked at $399K in Q2 2015.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Birch Hill Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.